Judrės medis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 3,445,872 | 3,305,836 | 3,525,020 | 5,793,335 | 13,833,959 | 11,670,866 | 9,280,265 | 9,849,306 |
| Profit before tax | 391,218 | 834,086 | 205,390 | 669,279 | 4,209,025 | 1,852,574 | -956,812 | 16,698 |
| Net profit | 390,578 | 792,212 | 205,390 | 669,279 | 3,714,540 | 1,841,703 | -956,812 | 16,698 |
| Equity | 1,601,417 | 2,396,578 | 2,581,968 | 3,251,247 | 6,956,787 | 8,398,490 | 7,112,678 | 7,117,610 |
| Liabilities | 1,119,851 | 598,785 | 613,028 | 1,461,851 | 1,921,856 | 409,777 | 845,810 | 1,075,353 |
| Non-current assets | 1,784,107 | 1,794,651 | 1,971,645 | 2,595,275 | 3,211,421 | 4,778,855 | 4,579,437 | 3,804,759 |
| Current assets | 958,286 | 1,391,912 | 1,360,954 | 2,200,156 | 5,681,983 | 4,010,226 | 3,319,319 | 4,335,824 |
| Total assets | 2,742,393 | 3,186,563 | 3,332,599 | 4,795,431 | 8,893,404 | 8,789,081 | 7,898,756 | 8,140,583 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,663,877 | 508,147 | 703,242 |
| Social insurance contributions | - | - | - | - | - | 241,749 | 288,414 | 332,444 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +39.3% | -4.1% | +6.6% | +64.3% | +138.8% | -15.6% | -20.5% | +6.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 14.2% | 24.9% | 6.2% | 14.0% | 41.8% | 21.0% | -12.1% | 0.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 24.4% | 33.1% | 8.0% | 20.6% | 53.4% | 21.9% | -13.5% | 0.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 11.3% | 24.0% | 5.8% | 11.6% | 26.9% | 15.8% | -10.3% | 0.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 11.4% | 25.2% | 5.8% | 11.6% | 30.4% | 15.9% | -10.3% | 0.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 0.2 | 0.2 | 0.4 | 0.3 | 0.0 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 119,510 | 113,020 | 122,255 | 179,638 | 360,886 | 303,797 | 216,660 | 211,813 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Judrės medis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-10 | 2025-02-10 | 10.28 |
| 2025-01-22 | 2025-01-30 | 10.28 |
| 2024-12-17 | 2024-12-20 | 25755.27 |
| 2024-11-18 | 2024-11-18 | 216.45 |
| 2024-07-26 | 2024-07-30 | 16.06 |
| 2024-07-16 | 2024-07-21 | 16.06 |
| 2024-06-18 | 2024-06-20 | 195.62 |
| 2024-04-23 | 2024-04-24 | 18.51 |
| 2024-04-16 | 2024-04-17 | 132.24 |
| 2022-04-19 | 2022-04-21 | 1150.90 |
| 2022-02-18 | 2022-02-20 | 67.21 |
| 2022-02-17 | 2022-02-17 | 72.58 |
Judrės medis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-10-26 | 2025-10-26 | 19.6 |
| 2025-10-25 | 2025-10-25 | 2804.76 |
| 2025-10-17 | 2025-10-24 | 2801.1 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Judres medis, UAB (code 163711216) is a Private Limited Liability Company active in logging. In 2025, the company generated revenue of €9.85M, up 6.1% year on year from €9.28M in 2024, but still below the €11.67M achieved in 2023. Net profit in 2025 was €16.7K, compared with a net loss of €956.8K in 2024 and net profit of €1.84M in 2023, indicating a return to positive earnings after a difficult prior year. The 2025 profit margin was 0.2%, showing very limited profitability. Balance sheet strength remained solid, with total assets of €8.14M, equity of €7.12M and liabilities of €1.08M. The equity ratio stood at 87.4% and debt to equity at 0.15, reflecting a conservative capital structure. Asset turnover was 1.21x, while ROE and ROA were both 0.2% in 2025. Revenue per employee reached €214.1K and profit per employee €363, suggesting strong sales generation but only minimal earnings conversion in the latest financial year.